NASDAQ:AGIO | Insider Transactions — Page 7 | AGIOS PHARMACEUTICALS, INC.

AGIO Insider Transactions — Page 7

638 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 601–638; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Biller ScottChief Scientific Officer2014-06-20Sale2,004.0$50.05
Higgons John DuncanChief Operating Officer2014-06-13Sale5,000.0$45.27
Higgons John DuncanChief Operating Officer2014-06-03Sale3,700.0$35.01
Higgons John DuncanChief Operating Officer2014-06-02Sale3,300.0$33.87
Biller ScottChief Scientific Officer2014-06-02Sale4,500.0$33.76
Higgons John DuncanChief Operating Officer2014-05-06Sale5,000.0$45.73
Goddard GlennSenior Vice President, Finance2014-05-01Sale2,000.0$42.39
Higgons John DuncanChief Operating Officer2014-05-01Sale7,000.0$42.39
Biller ScottChief Scientific Officer2014-05-01Sale4,500.0$42.39
MARAGANORE JOHNDirector2014-04-29Purchase2,250.0$44.0
CELGENE CORP /DE/TenPercentOwner2014-04-29Purchase294,800.0$44.0
Celgene European Investment Co LLCTenPercentOwner2014-04-29Purchase294,800.0$44.0
Celgene Alpine Investment Co., LLCTenPercentOwner2014-04-29Purchase294,800.0$44.0
Higgons John DuncanChief Operating Officer2014-04-07Sale3,000.0$45.17
Goddard GlennSenior Vice President, Finance2014-04-07Sale2,000.0$45.17
Goddard GlennSenior Vice President, Finance2014-04-01Sale4,000.0$38.08
Higgons John DuncanChief Operating Officer2014-04-01Sale12,000.0$38.08
Biller ScottChief Scientific Officer2014-04-01Sale4,500.0$38.08
Goddard GlennSenior Vice President, Finance2014-03-07Sale12,000.0$45.1
Higgons John DuncanChief Operating Officer2014-03-07Sale9,000.0$45.1
Goddard GlennSenior Vice President, Finance2014-03-06Sale5,468.0$35.54
Higgons John DuncanChief Operating Officer2014-03-06Sale5,646.0$35.54
Higgons John DuncanChief Operating Officer2014-03-03Sale8,000.0$29.85
Biller ScottChief Scientific Officer2014-03-03Sale6,000.0$29.85
Goddard GlennSenior Vice President, Finance2014-02-18Sale3,532.0$35.06
Higgons John DuncanChief Operating Officer2014-02-18Sale2,354.0$35.06
Goddard GlennSenior Vice President, Finance2014-02-10Sale6,000.0$30.44
Higgons John DuncanChief Operating Officer2014-02-03Sale8,000.0$25.97
Biller ScottChief Scientific Officer2014-02-03Sale6,000.0$25.97
Goddard GlennSenior Vice President, Finance2014-01-27Sale7,000.0$26.29
Biller ScottChief Scientific Officer2014-01-21Sale6,000.0$34.71
Higgons John DuncanChief Operating Officer2014-01-21Sale12,000.0$34.71
Goddard GlennSenior Vice President, Finance2014-01-21Sale10,000.0$34.71
CELGENE CORP /DE/TenPercentOwner2013-07-29Purchase708,333.0$18.0
Celgene European Investment Co LLCTenPercentOwner2013-07-29Purchase708,333.0$18.0
Celgene Alpine Investment Co., LLCTenPercentOwner2013-07-29Purchase708,333.0$18.0
Tessier-Lavigne MarcDirector2013-07-24Purchase55,555.0$18.0
MARAGANORE JOHNDirector2013-07-24Purchase8,333.0$18.0